Dual Medium Culture for Corneal Endothelial Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for culturing corneal endothelial cells face challenges in maintaining their morphology and characteristics during propagation, often leading to fibroblastic transformation, and are limited by the availability of donor corneas and risks of graft rejection in transplantation.
Innovation Solution
A dual medium approach using Human Endothelial-Serum Free Medium (Human Endothelial-SFM) supplemented with 5% serum as a maintenance medium and a proliferative medium for corneal endothelial cells, which stabilizes and expands the cells while preserving their morphology and characteristics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If corneal endothelial cells are propagated for at least three rounds of passages to achieve sufficient cell numbers, then the quantity of cells is improved, but the cells may develop into fibroblastic-like cells and lose their characteristic morphology
Solution Approach 1:
The patent changes the chemical composition parameters of the culture medium by incorporating specific growth factors (EGF, FGF, IGF, VEGF) and adjusting serum concentration levels. This parameter modification enables the medium to support both cell proliferation and morphology maintenance, preventing fibroblastic transformation while achieving sufficient cell numbers for research and transplantation applications.
2Reliability
If current corneal transplantation is performed to treat endothelial cell loss, then short-term success is achieved, but graft rejection risk and long-term graft failure remain problems
Solution Approach 1:
The patent creates in vitro copies of corneal endothelial cells through controlled culture and expansion. These lab-generated cells serve as alternatives to donor corneas for transplantation, potentially eliminating the need for donor organs and reducing rejection risks associated with allografts. The cultured cells can be used for autologous transplantation, matching the patient's own tissue characteristics.
3Device complexity
If isolated primary corneal endothelial cells are cultured in a single medium type, then the culture process is simplified, but the cells cannot be both expanded and maintained with their characteristic morphology
Solution Approach 1:
The patent segments the culture medium into distinct functional components: a basal medium providing essential nutrients, specific growth factors (EGF, FGF, IGF, VEGF) for proliferation and differentiation, and controlled serum levels for morphology maintenance. This segmented approach allows each component to perform its specific function, enabling both cell expansion and morphology preservation without requiring multiple separate media systems.
Data Source
Figure 1A~1I
Figure 2~3
Figure 4A~5
AI summary
The invention relates to a dual-media approach for culturing isolated corneal endothelial cells. Isolated corneal endothelial cells are first contacted with a proliferative medium to propagate and/or expand the endothelial cells followed by a maintenance medium to preserve the morphology and/or characteristics of the corneal endothelial cells. The invention includes the proliferative medium and the maintenance medium and also a combination of the two medium.